265. Lipodystrophy
109 clinical trials,   164 drugs   (DrugBank: 59 drugs),   26 drug target genes,   94 drug target pathways

Searched query = "Lipodystrophy", "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02647853
(ClinicalTrials.gov)
October 20143/1/2016Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy VolunteersA Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose, Phase 1 Study to Assess the Safety and Tolerability of TAT4 GelNasolabial Folds;Lipoatrophy;LipodystrophyDrug: TAT4 Gel concentration A;Drug: TAT4 Gel concentration B;Drug: PlaceboTopokine Therapeutics, Inc.NULLCompleted40 Years70 YearsBoth16Phase 1United States